The largest database of trusted experimental protocols

34 protocols using adcc reporter bioassay kit

1

FcγRIIIa Stimulation Assay for ADCC Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Our ADCC reporter system consisted of an Fc region of an antibody that binds to the FcγRIIIa receptor expressed on an engineered, immortalized Jurkat T-lymphocyte cell line. This binding can activate gene transcription through the nuclear factor of activated T cells pathway, inducing the expression of firefly luciferase.38 (link), 39 (link) This FcγRIIIa stimulation assay can be used to evaluate the ability of an antibody to activate the ADCC reporter gene. Here we performed the FcγRIIIa stimulation assay using an ADCC Reporter Bioassay kit from Promega according to the manufacturer's instructions. In brief, H9/IIIB or 293 T cells expressing HIV-1 Env (2.5 × 104 cells in 25 μL) as the target cells were seeded in each well of a 96-well flat-bottomed culture plate. A measure of 50 μL of serially diluted antibody was added to the culture plates. As the effector cells, engineered, immortalized Jurkat T lymphocytes from Promega expressing the FcγRIIIa receptor (1.5 × 105 cells in 25 μL) were co-cultured with the antibody-treated target cells at 37 °C for 24 h, and the luciferase activity was then measured using luciferase assay regents (Promega) and a luminescence counter (Infinite M200 Pro).
+ Open protocol
+ Expand
2

Antibody-Dependent Cell-Mediated Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADCC was measured using the ADCC Reporter Bioassay kit (Promega, Madison, WI, USA) according to the manufacturer’s instructions. ADCP was measured using the FcyRIIa-H Reporter Kit (Promega). Luminescence was measured immediately using a Synergy Hybrid Reader (BioTek Instruments, Inc., Winooski, VT, USA).
+ Open protocol
+ Expand
3

ADCC Reporter Bioassay for Antibody-Mediated Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ADCC Reporter Bioassay Kit (Promega Life Sciences) was used to measure the induction of ADCC by serum antibodies. The 293T cells were seeded on poly-D lysine coated, flat bottom white 96-well tissue culture plates (Costar) at 50,000 cells per well the day before transfection. Twenty-four hours later, cells were transfected with pCAGGS PR8 M2 (200 ng/well). The next day, transfected cells were washed with 100 µL of PBS and supplemented with 25 µL of Roswell Park Memorial Institute (RPMI) medium (Thermo Fisher Scientific). Pooled mouse sera were diluted 1:3 (from a starting dilution of 1:30) in RPMI medium and added (25 µL per well) to the transfected cells in triplicates. ADCC mouse effector cells (Promega Life Sciences) were added at a concentration of 75,000 cells per well and incubated for 6 h at 37 °C. At the end of the incubation, 75 µL of Bio-Glo luciferase assay substrate (Promega Life Sciences) was added to each well and incubated at RT for 5 min. Luminescence was read using a Synergy 4 microplate reader (BioTek) and Gen5 2.09 software. Fold induction over baseline was calculated and graphed using Prism 7.0.
+ Open protocol
+ Expand
4

ADCC Assay for Monoclonal Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADCC capacity of each MAb was measured using an ADCC Reporter Bioassay kit (Promega) largely in line with the manufacturer’s instructions. In brief, 3 × 104 Vero.E6 cells per well were seeded in white-bottom 96-well plates (Corning) and infected with VSV-ANDV in MEM at an MOI of 1 16 h later. After 2 days of incubation with virus at 37°C, 3-fold serial dilutions of each MAb were prepared in MEM, starting with 90 μg/ml. A negative-control antibody (KL-2G12) was used as well for determining the background. These MAbs were then added to the infected plate with effector cells from the Promega kit at a ratio of 3:2 (effector cells to infected cells) and additional medium such that the effective starting concentration of each MAb was 30 μg/ml. The plates were then incubated at 37°C for 6 h. Bio-Glo Luciferase reagent (Promega) was then added, and luminescence was measured immediately.
+ Open protocol
+ Expand
5

ADCC Receptor Engagement Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using the Promega ADCC reporter bioassay kit and a published protocol, in vitro engagement of the ADCC receptor was assessed [35 ]. MDCK cells were infected at a multiplicity of infection of 1 overnight with each respective virus, as mentioned earlier in the IF assay section. The next morning, antibody dilutions were added onto the cells in addition to 75,000 effector cells per well. Cells were then left in the 37°C incubator for six hours. The luciferase substrate was added in the dark and the luminescence activity was read after 5 min using Synergy Hybrid Reader (BioTek). Anti-stalk mAb CR9114, which has known ADCC reporter activity and binding to H4 HA, was used as a positive control [29 (link),57 (link),58 (link)]. Fold induction over an irrelevant antibody (anti-Lassa GPC) was calculated and data were analysed in Prism 7.
+ Open protocol
+ Expand
6

ADCC Reporter Bioassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ADCC reporter bioassay was performed using an ADCC Reporter Bioassay kit from Promega, following the manufacturer's instructions. Target cells (12,500 cells per well) were inoculated into a 96‐well white solid plate. H2Mab‐77‐mG2a‐f, H2Mab‐77, and 281‐mG2a‐f were serially diluted and added to the target cells. Jurkat cells stably expressing the human FcγRIIIa receptor, and a nuclear factor of activated T cells (NFAT) response element driving firefly luciferase, were used as effector cells. The engineered Jurkat cells (75,000 cells in 25 μL) were then added and cocultured with antibody‐treated target cells at 37°C for 6 h. Luminescence using the Bio‐Glo Luciferase Assay System (Promega) was measured with a GloMax luminometer (Promega).
+ Open protocol
+ Expand
7

ADCC Assay for Antibody Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ADCC reporter bioassay kit (Promega) was used to assess whether any of the MAbs elicit ADCC activity. The protocol has been described previously but was modified as needed (14 (link), 23 (link)). Vero.E6 cells (50,000 per well) were added onto white round-bottom 96-well cell culture plates (Corning Costar) and infected with VSV-LASV at a multiplicity of infection (MOI) of 1.0. Virus was prepared in MEM, and this medium was removed from the cells after 16 h. Twofold serial dilutions of each antibody were added to the cells in duplicate starting from a concentration of 100 µg/ml. Seventy-five thousand effector cells were added to the cells with the antibody dilutions, and cells were incubated at 37°C for 6 h. Luciferase substrate was added, and luminescence was measured 2 to 5 min later using a Synergy Hybrid Reader (BioTek). Human monoclonal antibody CR9114 was used on influenza virus (A/duck/Czechoslovakia/1956 H4N6)-infected Vero.E6 cells as a positive control (42 (link), 43 (link)).
+ Open protocol
+ Expand
8

ADCC Bioassay with SLA-silenced ICCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genetically engineered SLA‐silenced ICCs‐derived cells from four different donors per group were harvested and seeded on a white flat 96‐well plate at day zero. At day 1, different antibody concentrations were added together with Jurkat effector cells from ADCC Reporter Bioassay Kit (Promega) with an effector:target ratio of 6:1. Cells were incubated for 6 hours at 37°C in a humidified CO2 incubator. After incubation, plates were taken from the incubator and a Bio‐Glo Luciferase Assay Reagent was added. The levels of bioluminescence were measured using a luminometer (Berthold Technologies GmbH).
+ Open protocol
+ Expand
9

Evaluating ADCC Activity of N6 mAbs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess potential ADCC activity of the N6 mAbs the ADCC reporter bioassay kit from Promega was used (57 (link)). MDCK cells (25,000 cells/well) were seeded in a white, flat bottom 96- well cell culture plate (Corning). The following day the cells were washed with PBS and then infected with an MOI of 1 with the respective virus at 37°C for 16h. On the following day, antibody dilutions were prepared using a starting concentration of 100 µg/ml. The antibodies were serially diluted 1:3 and then added in duplicates to the cells. The human derived monoclonal antibody CR9114 (56 (link)) was included as a positive control and an irrelevant anti-Lassa virus antibody [KL-AV-1A12 (53 (link))] was used as a negative control. Next, 75,000 effector cells/well were added to the plate and incubated for 6 h at 37°C. The luciferase substrate was added in the dark and the luminescence activity measured after 5 minutes using a Synergy Hybrid Reader (BioTek). The antibodies were run in duplicates and the data was analyzed using GraphPad Prism 7.
+ Open protocol
+ Expand
10

ADCC Reporter Bioassay for Antibody Titer

Check if the same lab product or an alternative is used in the 5 most similar protocols
All sera were heat inactivated, serially diluted and analysed using ADCC Reporter Bioassay kit (Promega), as previously described (22 (link)). MDCK cells infected with NIBRG-14 virus at multiplicities of infection (MOI) 0.34 were used as target cells, and Jurkat/NFAT-luc cells were used as effect cells. The antibody-dependent cellular cytotoxicity (ADCC) reporter activity was measured with Bio-Glo Luciferase Assay Reagent (Promega) as relative luciferase activity (RLA). ADCC titer (EC50) was calculated as the reciprocal dilution of sera giving 50% of maximum RLA. Non-detected samples were assigned a value of 2 for calculation purpose.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!